 transgender care. He believes those are bad not only because they've gender transitioned medicine, but because he believes big pharmaceutical corporations are in effect preying on vulnerable young people to pad their bottom lines by selling them expensive hormones. So he frames some of these economic issues in cultural terms and he frames cultural issues in economic terms. So that's where he's a bit different.